Home / Resources / Annual Completed Clinical Trials Report Infographic

Annual Completed Clinical Trials Report Infographic

インフォグラフィック
研究開発支援サービス
Citeline Trialtrove subscriber accessing data of completed clinical trials.

After a year of decline in 2022, completed clinical trials were on the upswing again in 2023. According to Trialtrove, 4,295 industry-sponsored Phase I-Phase III/IV clinical trials either reached completed status or reported primary endpoints during 2023. This is a 10.7% increase over 2022.

Related products
Surfacing insights for a successful clinical trial
Trialtrove
臨床試験の戦略、設計、実施のための頼りになる情報リソース
Getting the full drug RandD landscape
Pharmaprojects
世界的な医薬品研究開発の状況を追跡し、分析するための業界標準
Citeline consulting expert providing actionable insights on feasibility activities.
サービスとしての実現可能性（FaaS）
最先端の分析ソリューションは、臨床プロセスを加速し、成功を予測することができます。

Related resources

Infographic Banner for Pharma R&D Annual Review 2024 Supplement NAS Infograpic
MAY 09, 2024
インフォグラフィック
研究開発支援サービス

Pharma Annual R&D Review 2024 Supplement Infographic: New Active Substances Launched During 2023

Highlights from the Pharma R&D Review 2024 Supplement, a look at new active substances (NASs), drugs launched onto the market for the first time, in 2024.

Q2 2024 Outlook Report
APR 08, 2024
レポート
商業化支援サービス

Q2 2024 Outlook Report

Discover the catalysts, deals and likelihood of approval for 22 key drugs, devices and diagnostics expected to occur in Q2 2024.

Citeline subscribers accessing the 2023 Deal-Making Roundup white paper reported by Biomedtracker.
MAR 28, 2024
ホワイトペーパー
商業化支援サービス

2023 Deal-making Roundup

An overview of alliance, M&A, and financing deal activity across the
worldwide biopharma, medical device, and in vitro diagnostics
industries in 2023